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Abstract
Activation of hepatic stellate cells has been recognized as one of the first steps in liver injury and repair. During activation,
hepatic stellate cells transform into myofibroblasts with concomitant loss of their lipid droplets (LDs) and production of
excessive extracellular matrix. Here we aimed to obtain more insight in the dynamics and mechanism of LD loss. We have
investigated the LD degradation processes in rat hepatic stellate cells in vitro with a combined approach of confocal Raman
microspectroscopy and mass spectrometric analysis of lipids (lipidomics). Upon activation of the hepatic stellate cells, LDs
reduce in size, but increase in number during the first 7 days, but the total volume of neutral lipids did not decrease. The
LDs also migrate to cellular extensions in the first 7 days, before they disappear. In individual hepatic stellate cells. all LDs
have a similar Raman spectrum, suggesting a similar lipid profile. However, Raman studies also showed that the retinyl
esters are degraded more rapidly than the triacylglycerols upon activation. Lipidomic analyses confirmed that after 7 days in
culture hepatic stellate cells have lost most of their retinyl esters, but not their triacylglycerols and cholesterol esters.
Furthermore, we specifically observed a large increase in triacylglycerol-species containing polyunsaturated fatty acids,
partly caused by an enhanced incorporation of exogenous arachidonic acid. These results reveal that lipid droplet
degradation in activated hepatic stellate cells is a highly dynamic and regulated process. The rapid replacement of retinyl
esters by polyunsaturated fatty acids in LDs suggests a role for both lipids or their derivatives like eicosanoids during
hepatic stellate cell activation.
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Introduction
Hepatic stellate cells (HSCs) are non-parenchymal cells located
perisinusoidally in the space of Disse and comprise about 5–10%
of the total liver cell population [1]. HSCs play an important role
in the turnover of hepatic extracellular matrix (ECM). They
synthesize extracellular matrix proteins and secrete metalloprotei-
nases to maintain the 3D structure of the liver in a dynamic way
[2,3]. During the process of liver injury and repair, HSCs become
activated, and the quiescent HSC undergoes a gradual transfor-
mation from a non-dividing phenotype into a proliferative
myofibroblastic phenotype [4,5]. HSC activation and subsequent
production of excessive ECM are therefore recognized as initial
steps in the process of liver cirrhosis [6]. It is therefore important to
understand the molecular mechanism that underlies the activation
process of HSCs.
Quiescent HSCs have a lipid storing phenotype as indicated by
the presence of large lipid droplets (LDs). During the activation
process the HSCs lose their LDs [7]. LDs exist of a core of neutral
lipids, surrounded by a phospholipid monolayer [8]. In most cells
the neutral lipid stored in the LDs consists of triacylglycerols
(TAG) and cholesterol esters. In HSCs, the LDs contain in
addition to these neutral lipids also retinyl esters (RE). In fact, the
surplus of retinol/vitamin A is mainly stored as RE in HSCs
[9,10]. The existence of two types of LDs is described in HSCs
[10], although it is unknown whether one of these pools exclusively
contains RE. Of the stored RE, retinyl palmitate is the most
abundant species in rat HSC, followed by retinyl stearate and
retinyl oleate [11]. The preferred esterification of retinol with
saturated fatty acid species is mediated by the enzyme lecithin:re-
tinol acyltransferase (LRAT) [12].
One of the unresolved issues in the field of HCS research is,
whether the decrease in LDs is causally related to the activation
PLoS ONE | www.plosone.org 1 April 2012 | Volume 7 | Issue 4 | e34945process. In other words can HSC activation be altered when
formation or breakdown of lipid droplets is disturbed? In order to
answer this question first a more fundamental knowledge on the
molecular mechanism of lipid droplet homeostasis in HSC is
required as this is largely lacking at the moment. To acquire more
insight in the mechanism of LD loss, and its role in HSC
activation, we investigated the LD degradation process and
lipidomic alterations in these cells with a combined approach of
Raman confocal microspectroscopy and high performance liquid
chromatography (HPLC)-coupled mass spectrometry (MS). Ra-
man microspectroscopy - a spectroscopic technique based on
inelastic scattering of monochromatic light - does not require
labeling of the molecules of interest and enables direct specific
chemical imaging of biomolecules such as DNA/RNA, proteins,
and lipids in intact cells and tissues [13,14]. More importantly, it
provides detailed information about the molecular composition of
the subcellular volume being probed [15]. Together with a newly
developed MS technique enabling analysis of all neutral lipid
classes in a single run, we could follow LDs morphologically and
biochemically during the HSC activation process in vitro. Isolation
of HSCs and subsequent culturing on a plastic surface induces
phenotypical alterations resembling the in vivo HSC activation
process and is therefore commonly used as a model to study HSC
activation.
Here, we report that HSCs display a homogeneous LD
population with respect to their chemical content. Upon activation
LDs drastically change in size, intracellular location and lipidome.
Especially a preferential decrease in retinyl esters was observed in
the early stages of activation that was accompanied by a specific
increase in triglycerides containing polyunsaturated fatty acids.
This shows that lipid droplet degradation in activated hepatic
stellate cells is a highly dynamic and regulated process.
Results
Redistribution of lipid droplets during HSC activation
To investigate the dynamics of the LD degradation process,
freshly isolated HSCs were cultured and fixed at several time
points, where after LD morphology and distribution was analysed.
In its quiescent form, the HSC is relatively small and star-shaped
(Fig. 1A-day 0). During the activation process, the HSC forms
cellular extensions (Fig. 1A-day7 arrow), until its final transfor-
mation into a myofibroblastic cell (Fig. 1A-day 14). a-smooth
muscle actin staining, commonly used as a HSC activation
marker, confirmed the activated state of HSCs at day 7 and 14
(not shown). In the quiescent HSC numerous large LDs were
observed perinuclearly (Fig. 1A-day 0). In HSCs around day 4
after plating an increased number of smaller LDs was visible,
Figure 1. HSC activation results in redistribution of LDs and is accompanied by a decrease in size. A. Freshly isolated HSCs were cultured
and fixed after 2 h (day 0), and 4, 7 or 14 days. Morphology and neutral lipid content was analyzed by differential interference contrast microscopy
(DIC) and fluorescence microscopy after Bodipy staining of LDs. Arrows indicate LD redistribution. B. Total number of LDs in HSCs at day 0, 4, 7 and
14 and the area per LD was quantified by Image J software. The results represent the means 6 SEM of 10 representative cells.
doi:10.1371/journal.pone.0034945.g001
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many (newly formed) cell extensions. Quantification of LD size
and number by Image J analysis confirmed that the size of the LDs
decreased during the first days of activation, and remained similar
between day 4 and 7 after plating, whereas the number of LDs
continually increased (Fig. 1B). From these data, it can be
calculated that the total volume of neutral lipids per cell did not
decrease during the first 7 days. In the successive period the LDs
were completely degraded, as 2 weeks after isolation hardly any
LDs could be observed in the myofibroblastic HSCs (Fig. 1A-
day14, 1B).
To investigate the fate of individual lipids in the LDs upon HSC
activation in more detail, freshly isolated HSCs were incubated for
5 hr with 25 mM Bodipy-C12, a fluorescent fatty acid which is
rapidly incorporated into TAG. After the incubation period,
fluorescent fatty acid was accumulated in perinuclear LDs (Fig.
S1). HSCs were subsequently cultured in the absence of exogenous
Bodipy-C12 to follow the incorporated lipid in time. At day 4,
fluorescently labelled LDs were detected at the cell extensions (Fig.
S1). At day 7 fluorescent LDs were still observed at the growing
cell tips (not shown), suggesting that the small LDs were at least
partly derived from the larger perinuclear droplets rather than
completely de novo formed from (unlabeled) lipids imported from
the medium.
The notion that small peripheral LDs are derived from the large
perinuclear LDs predicts that the LDs migrate to the cell
extensions of activated HSCs. We therefore performed time-lapse
live cell imaging on HSCs around day 3–4 after plating. At this
time point the most dramatic alterations were observed in LD
localization and cellular reshaping. As shown in Fig. 2A and
Movie S1, migration of perinuclear LDs towards the growing cell
extensions was apparent. LD redistribution could be disturbed by
treatment with nocodazole, an agent affecting microtubule
organisation, and LDs were scattered through the cytoplasm
(Fig. 2B). This suggests that redistribution of the LDs towards the
cell extensions is mediated by the microtubule system. In addition,
nocodazole treated cells had less clear cell extensions in
comparison with the control cells.
In order to obtain insight in the mechanism of the observed
changes in LD number and size, we determined the level of a
number of proteins implicated in LD formation in HSCs at day 1
and after activation at day 7 (See Fig. S2). We found minor
changes in the level of diacylglycerol acyltransferase 2 (DGAT2),
implicated in TAG synthesis. In contrast, LRAT, an enzyme
responsible for the synthesis of RE, was down regulated during
HSC activation. The level of a key enzyme in phosphatidylcholine
(PC) synthesis, CTP:phosphocholine cytidylyltransferase alpha
(CCTa) was somewhat lower in activated HSCs. The subcellular
localization of CCTa as determined by immunofluorescence
microscopy, was not different between day 1 and day 7 and was
mostly nuclear (data not shown),
Raman spectrum of retinyl esters is changed in activated
HSC
During the activation process the localisation and size of the
LDs altered dramatically. To address whether the LD composition
changed as well, confocal Raman microspectroscopy was used to
investigate the LD composition of HSCs in the quiescent and
activated state. Due to its conjugated structure, retinoids display a
specific Raman spectrum. As seen in Fig. 3 (upper right panel) RE
are abundantly present in quiescent HSCs, with a characteristic
main peak at 1595 cm
21 and a number of smaller peaks in the
region between 900 and 1300 cm
21 (marked with asterisks). Also
the acyl chains of fatty acid containing lipids like TAG could be
well detected by their characteristic peak at 1440 cm
21 (C-H
bending; marked with #) and a peak around 1660 cm
21, which is
partly obscured in the presence of the main retinyl peak, if present.
By determining the ratio between the main retinyl peak
(1595 cm
21) and the acyl peak at 1440 cm
21 both in HSC
samples and in different mixtures of trioleylglycerol and retinyl
palmitate standards, we could make an estimate of the retinyl
content of the LDs. By this method, we found that approximately
10% of the LD content of quiescent HSCs consisted of
retinylesters. However upon activation of the HSCs, a drastic
decrease in the level of RE relative to triacylglycerol was seen
Figure 2. LD redistribution during HSC activation is microtubule dependent. A. Frames from time lapse life cell analysis revealing
redistribution of dynamic LDs towards growing cellular extensions. Tracking shows the typical movements of a dynamic LD from 72 h to 84 h of HSC
activation. Arrows indicate other regions of dynamic LDs (trackings not shown). B. To examine microtubule involvement in the LD redistribution
process, freshly isolated HSCs were after 24 h in culture either treated with 10 mM nocodazole or vehicle (control) for 72 h at 37uC and after fixation,
morphology and LD localization were analyzed by differential interference contrast microscopy (DIC) and fluorescence microscopy after Bodipy
staining.
doi:10.1371/journal.pone.0034945.g002
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activated cells at day 7 (Fig. 3).
(Activated) HSCs contain a homogenous LD population
In the initial period of the activation process both large
perinuclear LDs and small dynamic LDs in cell extensions could
be observed. To investigate whether the lipid composition of both
LD types was similar, confocal Raman microspectroscopy was
performed on perinuclear and peripheral LDs in HSCs at day 0, 4
and 7. As can be seen in the cluster images in Fig. 3 the Raman
spectra of all LDs at day 0 contain a similar profile, with the same
ratio between the peak at 1595 cm
21 (retinyl ester) and
1440 cm
21 (TAG species). Also at day 4 and day 7 all LDs
within one cell showed a similar spectrum, although as described
above, different from that in quiescent HSCs. (Fig. 3; lower
panels). These results indicate that HSCs contain a homogenous
LD population with respect to their neutral lipid composition,
which is independent of their size, their state of activation and/or
localization.
To measure the metabolic activity of the LDs, we applied
deuterated arachidonic acid (20:4-d8/AA-d8; 25 mM) to HSCs.
Deuteration allowed the discrimination of exogenously adminis-
tered fatty acids from endogenous lipids by a characteristic peak
around 2200–2300 cm
21 of the C-D bond in the Raman
spectrum [16]. All LDs at day 7 display a similar localization of
the characteristic deuterium signal and the retinyl signal (Fig. 4A).
This indicates that AA-d8 was incorporated in all LDs, both
perinuclear and in the cell extensions. To obtain independent
evidence for a similar metabolic activity of all LDs within one cell,
we added the fluorescently labelled fatty acid, Bodipy-C12, to
activated HSCs. Within one cell all LDs had incorporated similar
levels of fluorescent fatty acid (Fig. 4B), although we could observe
some differences in uptake between different cells plated at the
same time.
HSC activation results in a decrease in retinyl esters and
an induction of polyunsaturated triacylglycerol species
Our results suggest the presence of highly dynamic and
metabolically active LDs. Therefore, we considered the possibility
that both the lipid class profile and the lipid species (i.e. fatty acid)
profile within a lipid class changed during HSC activation. We
analysed the neutral lipid species profile of quiescent and activated
Figure 3. HSC activation results in a decrease in retinyl esters in HSC LDs. Freshly isolated HSCs were cultured and fixed after 2 h (day 0;
quiescent state), and day 4 and day 7 (activated state). Confocal Raman microscpectroscopy on LD enriched regions was performed as described in
the Method section. Cluster image (20620 mm
2) was constructed from Raman imaging data of the square area in the white light image. Each color
represents a different cluster. The cluster averages show the average Raman spectra extracted from the black, pink, green and blue clusters displayed
in the cluster image. * indicates (characteristic) RE peaks; # indicates characteristic acyl peak.
doi:10.1371/journal.pone.0034945.g003
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lipids consisted of RE in quiescent HSCs (Fig. 5A). The main RE
species was retinyl palmitate (6868%), followed by retinyl stearate
(1764%). The remainder being retinyl linoleate and retinyl oleate
(763% and 963%, respectively; n=3). In accordance with the
Raman experiments, a strong decline in the RE amount (mainly
retinyl palmitate) was seen on day 4 after plating, and this decline
continued upon further activation (Fig. 5B). However, activated
cells had a somewhat increased level of TAG and a 2–3 fold higher
level of cholesterol esters (Fig. 5B). Surprisingly, in activated HSCs
TAG species with relatively high m/z values between 900–1050
were much more enriched, than species with lower m/z values like
TAG (18:2,18:2,18:2), (Figs. 5B, 6A and 6B). Further analysis by
MS/MS of the TAG species that were elevated in activated HSCs
showed that most of the increased high m/z species had one or
more long chain polyunsaturated fatty acids (PUFA) incorporated
i.e. fatty acids of 20 and 22 carbon chain length and 4 or more
double bonds. The most predominant PUFA was docosapentae-
noic acid (22:5). Quantification of the TAG species containing two
or three PUFAs (TAG-PUFAs) revealed that they were hardly
detectable in quiescent HSC (Fig. 6C), but increased more than
10-fold upon activation. Especially TAG species with three PUFA
moieties were specific for activated HSC at day 7 (Fig. 6C). After
prolonged culture for one month, no TAG-PUFAs were present
any more (data not shown).
HPLC-MS analysis of the phospholipid fractions of HSCs at
day 0, 4 and 7 revealed no increase in PUFA species in
phosphatidylcholine (PC), the most abundant phospholipid, upon
activation (Fig. 6B). For a detailed PC-PUFA analysis see Fig. S3.
Similar results were observed for phosphatidylethanolamine (PE),
phosphatidylinositol (PI) and phosphatidylserine (PS) species (not
Figure 4. HSCs contain a metabolically homogenous population of LDs. A. Freshly isolated HSCs were cultured for 6 days and additionally
incubated with 25 mM deuterated arachidonic acid (AA-d8) for another 24 h. After fixation confocal Raman microspectroscopy was performed as
described. Raman images in the 1595 cm
21 (RE) and 2180–2280 cm
21 (AA-d8) regions are shown in arbitrary units for LD enriched sites perinuclearly
(upper panels) and at the cell extension (from a different cell; lower panels). B. To determine metabolic activity of HSC LDs, freshly isolated HSCs were
cultured for 4 days and subsequently incubated for 5 h with 25 mM Bodipy C-12. After fixation cells were analyzed by fluorescence microscopy.
doi:10.1371/journal.pone.0034945.g004
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and not observed in phospholipids.
Incorporation of exogenous arachidonic acid is increased
during HSC activation
PUFAs can be imported into cells or synthesized from various
precursors by elongation and desaturation, starting from linoleic
acid (18:2) or linolenic acid (18:3; for an overview of the PUFA
(22:5) synthesis pathway see Fig. 7A). To investigate the origin of
the observed TAG-PUFAs species, freshly isolated HSCs were
incubated with deuterated linoleic acid (18:2-d4) or arachidonic
acid (20:4-d8) for 7 days. Analysis of TAG species by HPLC-MS
showed a higher incorporation of 20:4-d8 in comparison with
18:2-d4, (Fig. 7B). Not only 20:4-d8 containing TAG species were
increased, but deuterated 22:4 and 22:5 species were also present,
indicating elongation and desaturation of the imported fatty acids
(Fig. 7B). As arachidonic acid was preferentially incorporated, we
studied its incorporation and subsequent conversion in closer
detail during the HSC activation process. HSCs in different states
of activation were incubated for 24 h with 20:4-d8 (Fig. 7C).
Whereas quiescent cells incorporate only minor quantities 20:4-d8
in 24 h, the incorporation in activated cells was drastically
increased (Fig. 7C and D). At day 7, activated HSCs incorporated
15–20 times more deuterated lipid than HSCs at day 1, in
particular in the 20:4, 22:4 and 22:5 containing TAG species
(Fig. 7D).
Discussion
Raman microspectroscopy and HPLC-MS showed that the
relative retinyl ester content in quiescent HSCs amounted to 10%
and 15–20%, respectively, of the neutral lipid fraction. The
somewhat lower percentage RE obtained by Raman measure-
ments might be explained by laser-induced photo-oxidation effects
of retinoids, as described by other groups [17]. Our findings
indicate a lower percentage RE than the approximately 40–45%
described in other studies, but a similar species profile (i.e. retinyl
palmitate..retinyl stearate.retinyl oleate<retinyl linoleate)
[11,18]. It has been reported that the HSC LD composition is
significantly influenced by the dietary retinol intake and age [19].
The rats in our experiments were fed a comparable amount of
retinol (5 mg retinol/g dry food) and had similar weights (around
400 g) as described in the most frequently cited papers. However,
the detection method for retinoids and other lipids differed
between this study and the previous ones [11,18].
Upon activation HSC were thought to start loosing both their
RE and their LDs simultaneously. Based on our observations we
suggest that LD turnover during HSC activation occurs in two
phases. Initially, LDs redistribute from perinuclear regions towards
newly formed cellular extensions. During this first phase the total
LD volume does not decrease, but the LDs reduce in size and
increase in number. This might indicate fission of LDs during the
redistribution process. Fission of LDs has been observed recently
in fission yeast during cell cycle [20], although the mechanism of
LD fission remained obscure. Interestingly, rat HSCs are reported
to upregulate cell cycle proteins and DNA synthesis upon
activation [21]. The increase in the number of LDs also suggests
an increase in the amount of phospholipids, mainly PC,
surrounding the LDs. CTP:phosphocholine cytidylyltransferase
(CCT), a key enzyme involved in PC synthesis, was recently shown
to be required for the increase in LD number upon oleate addition
to mammalian cells [22]. However, we could not observe an
Figure 5. HSC activation results in a preferential decrease in retinyl esters. A. Neutral lipid composition of quiescent HSCs (day 0) analyzed
by HPLC-APCI-MS. The results represent the means 6 SEM of three experiments. B. Quantification of RE, cholesterol esters (CE), total TAG (TAG), and
TAG(18:2,18-2,18:2) content in HSC at day 0, 4 and 7. Values are expressed relative to the level of lipid present at day 0. The results represent the
means 6 SEM of three experiments.
doi:10.1371/journal.pone.0034945.g005
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suggesting that the existing CCTa levels suffice for the generation
of enough PC for the phospholipid monolayers covering the novel
LDs and for the newly formed cell extensions. The translocation of
the LDs towards the cell extensions probably involves directed
movement along microtubules as it was inhibited by nocadozole.
The signals and mechanism of LD movements are largely
Figure 6. PUFA-containing TAG species, but not phospholipid species, are induced during HSC activation. A. Contour plots of HPLC-
APCI-MS analysis of HSC at day 0 and 7, showing an increase in long chain fatty acid-containing TAG species at day 7. From every ion in the m/z 880–
1050 region its relative abundance (amount of blackness) and retention time in the HPLC separation is shown. TAG species with the same total
number of carbon atoms in the three acyl chains (denoted on the right hand side), but different number of double bonds (:n) form diagonal ‘‘stripes’’
at specific m/z regions. B. Quantification of the total amount of TAG-PUFA (m/z 900–1050) and PC-PUFA species in HSCs at day 0, 4 and 7. Values are
expressed relative to the level of lipid present at day 0. The results represent the means 6 SEM of three experiments. C. TAG species containing one,
two or three 22:5 acyl moieties are induced during HSC activation. The results represent the means 6 SEM of three experiments.
doi:10.1371/journal.pone.0034945.g006
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machinery [23].
In addition to changes in LD localization and morphology, the
LD lipid content alters as well. The RE concentration declines
considerably and TAG species containing PUFAs rise to relatively
high levels. The loss of RE, approximately 15% of total lipids in
LDs, is roughly similar to the amount of newly formed PUFA-
TAGs. So RE are apparently replaced by PUFA-TAGs in LDs
during the first phase. In the second phase of the LD degradation
process, the small LDs reduce further in size until hardly any LDs
are present in the activated, myofibroblastic HSC.
As demonstrated by Raman microspectroscopy no differences
in lipid composition between individual LDs within one cell were
observed, both in quiescent and activated HSCs. This indicates
that the intracellular LD population behaves homogeneously with
respect to RE degradation and other lipid metabolic pathways.
The molecular identity of the enzymes involved in LD degradation
in HSCs during activation is largely unexplored. Adipose
triglyceride lipase (ATGL) has an important role in LD
degradation in eukaryotic cells [24]. A contribution of hormone
sensitive lipase (HSL), an enzyme involved in LD degradation in
adipocytes, is less likely as this enzyme is relatively adipocyte
specific and has not been detected in hepatic stellate cells. Also
several proteins are implicated in RE hydrolysis, including
hepatocyte carboxylesterase ES-3, ES-4, ES-10 and ES-22
[25,26]. Recently, autophagy was found to play a role in the
degradation of lipids in activated mouse and human HSC’s [27],
implicating lysosomal lipases in the degradation process of LDs.
Figure 7. Incorporation of exogenous arachidonic acid into TAG is increased in activated HSCs. A. Overview of the omega-6 fatty acid
synthesis pathway. B. Analysis of deuterated 18:2 and 20:4 incorporation in several TAG-PUFA species. Freshly isolated HSCs were incubated for seven
days with 25 mM 18:2-d4 or 25 mM 20:4-d8. After neutral lipid extraction, HPLC-MS was performed as described. Values are expressed relative to the
level of the respective undeuturated TAG species present at day 7. The results represent the means 6 SEM of three experiments. C, D. Freshly
isolated HSCs were incubated at day 0, 3 or 6 with 25 mM 20:4-d8 for 24 h. Subsequently, neutral lipids were extracted and HPLC-APCI-MS analysis
was performed. C. Contour plots of HPLC-APCI-MS analysis of HSC at day 0 and 7 in the m/z 880–1050 region. Positions of unlabeled species are
indicated with a straight line and relative position of species with one or two d8-labeled acyl chains are indicated by dotted lines. Arrowheads
indicate TAG species with three d8-labeled acyl chains. D. Quantification of several TAG species containing d8-labeled acyl chains during HSC
activation. The results represent the means 6 SEM of three experiments.
doi:10.1371/journal.pone.0034945.g007
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reveal enzymes associated with the degradation/conversion of
cholesterol esters, TAGs and RE and unravel their roles in HSC
activation.
We demonstrated that the levels of TAGs and RE were not
decreased simultaneously upon HSC activation, suggesting a
specific lipolytic regulation for these two classes of lipids.
Alternatively, the lipid content (both TAGs and RE) of existing
LDs may be degraded simultaneously, but the resulting retinol and
fatty acids may be re-esterified at different rates. In support of this
latter possibility it was shown that in activated HSCs the enzyme
involved in esterification of retinol, i.e. LRAT, was more down
regulated than DGAT2, an enzyme involved in incorporation of
fatty acids into TAG [28] (Fig. S2).
The observation that RE are degraded in the initial phase of
HSC activation suggests a role for the released retinol or its
metabolites like retinoic acid, during liver injury and/or repair.
Recently, HSCs devoid of retinoid containing LDs, were shown to
have a similar effect on liver fibrosis as normal RE containing
HSCs, but caused a decrease in hepatic carcinogenesis [29].
Together with the loss of RE in the initial phase of HSC
activation, we demonstrated an enhanced incorporation of
exogenous arachidonic acid (AA) in TAG and formation of
TAG-PUFA species. The selective incorporation of PUFAs in
TAG implies the involvement of either i) specific transporters for
PUFAs, ii) enzymes which selectively couple PUFAs to CoAs or iii)
enzymes which selectively incorporate PUFA-CoAs into TAG.
Among the various enzymes known to be involved in these
pathways only the long-chain acyl-CoA synthetase 4 (ACSL4) was
described to be selective for AA and other C20 fatty acids [30].
However, no large increase in mRNA levels of this enzyme was
observed during HSC activation (unpublished observation; [31]).
Elevation of TAG-PUFA species during HSC activation could
be physiologically relevant in at least two different cellular
processes. First, long chain PUFAs are known to be abundantly
present in membrane phospholipids of sperm and neuronal cells,
affecting membrane fluidity and regulating the function of several
membrane associated proteins, including those involved in fusion
of transport organelles with the plasma membrane [32–33].
Neurons and spermatocytes have in common that they have long
cellular extensions, similar to activated HSC. As during transdif-
ferentiation from quiescent HSC to myofibroblast long extensions
are formed, phospholipids have to be synthesized to increase both
the membrane surface area and the fluidity of the extensions.
Although phospholipid analysis of total cell homogenates did not
show an enhancement of PUFA containing phospholipid species in
activated HSCs, specific enrichment of PL-PUFAs in the plasma
membranes of activated HSCs cannot be excluded.
A second process in which the increase in TAG-PUFAs may
play a role is the AA/eicosanoid metabolism. AA plays a central
role in inflammation and is involved in many pathological
conditions [34]. Cubero and colleagues report that in alcoholic
liver disease AA can accelerate ECM synthesis by HSCs, resulting
in liver cirrhosis [35]. AA is also a precursor for eicosanoids, which
are signaling lipids that play a role in a broad range of processes,
such as modulation of the immune system. In several types of
immune cells esterified AA has been found in isolated LDs [36]. It
has been suggested that in leukocytes such LDs serve as an AA
reservoir for local activation of essential cellular functions [16].
Also proteins involved in AA metabolism and transport were
found on the surface of LDs supporting the hypothesis that LDs
might have a central role in eicosanoid synthesis and secretion
[36]. The HSC has also been recognized as antigen presenting cell
involved in a range of immunological functions [37]. TAG-PUFAs
found in our lipidomic screen could therefore be storage pools,
waiting to be incorporated in phospholipids or used for local
eicosanoid synthesis, as described in immune cells.
In conclusion, we demonstrated that drastic lipidomic changes
take place during early HSC activation, including preferential RE
depletion and an increase in the formation of TAG-PUFA species.
These lipid species proved to be very characteristic markers for
HSCs in their initial activation state and underline the importance
of the lipidome during (patho)physiological alterations.
Materials and Methods
Ethics statement
Rats were treated according to the strict governmental and
international guidelines on animal experimentation, and were
approved by the Animal Experimentation Committee (Dierexper-
imentencommissie; DEC) of Utrecht University (DEC-numbers:
2009.III.08.076 and 2010.III.09.110).
Chemicals
Collagenase (Clostridium histolyticum Type I) was obtained
from Sigma-Aldrich (St. Louis, MO, USA). Dulbecco’s modified
Eagles’s medium (DMEM) and fetal bovine serum (FBS) were
from Gibco (Grand Island, NY, USA). Bodipy 558/568-C12 (D-
3835) and Bodipy 493/503 (D-3922) were from Molecular Probes
(Invitrogen, Carlsbad, CA, USA). Antibody against glial fibrillary
acidic protein (GFAP) was from BD Pharmingen (San Jose, CA,
USA), against a-smooth muscle actin (a-SMA) from Thermo
Scientific (Waltham, MA, USA), against diacylglycerol acyltrans-
ferase 2 (DGAT2) and b-actin from Abcam (Cambridge, MA,
USA), against lecithin:retinol acyltransferase (LRAT) from Santa
Cruz Biotechnology (Santa Cruz, CA, USA), and against
CTP:phosphocholine cytidylyltransferase alpha (CCTa) from Cell
Signaling Technology (Danvers, MA, USA), All HPLC-MS
solvents were from Biosolve (Valkenswaard, the Netherlands) with
exception of chloroform (Carl Roth, Karlsruhe, Germany) and
were of HPLC grade. Silica-G (0,063–0,200 mm) was purchased
from Merck (Darmstadt, Germany). Diacylglycerol (16:0,16:0),
TAG (18:1, 18:1, 18:1), cholesterol, CE (18:1), and retinyl
palmitate standards were from Sigma-Aldrich (St. Louis, USA).
Linoleic acid-d4 (18:2-d4) and arachidonic acid-d8 (20:4-d8/AA-
d8) were purchased from Cayman Chemical (Ann Arbor, MI,
USA).
Isolation and culture of HSC
Adult male Wistar rats (350–400 g) were used in all experi-
ments. Stellate cells were isolated from rat liver by collagenase
digestion followed by differential centrifugation [38]. Cell
isolations were performed under reduced light conditions to
prevent retinoid oxidation. After isolation, HSC were plated in
25 cm
2 culture flasks or on glass coverslips. Purity of the plated cell
population was checked routinely by immuno-staining of glial
fibrillary acidic protein (GFAP). Cells were maintained in
Dulbecco’s modified Eagles’s medium (DMEM) supplemented
with 10% fetal bovine serum (FBS), 100-units/ml penicillin and
100 mg/ml streptomycin and 4 ml/ml Fungizone. Medium was
changed every 4 days. Cells were protected from light exposure by
wrapping culture flasks and dishes in aluminium foil.
Fluorescence and live cell microscopy
Freshly isolated HSCs were grown on glass coverslips. Cells
were fixed at day 0, 4, 7 and 14 with 4% paraformaldehyde in
phosphate-buffered saline (PBS). For staining of the LDs, cells
were incubated with Bodipy 493/503 (final concentration
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analyzed using a LEICA DMR fluorescence microscope. Images
were analysed using Image J software. For the analysis lipid loss
from LDs during the activation process, freshly isolated HSCs
were incubated with 25 mM Bodipy 558/568-C12 for 5 h at 37uC.
After washing to remove the excess of fluorescent lipid, cell culture
was continued, and cells were fixed with 4% paraformaldehyde at
several time points. To study the dynamics of lipid incorporation
into LDs during the HSC activation process, cells at day 0, 4 and 7
were incubated with 25 mM Bodipy 558/568-C12 for 5 h at 37uC
and fixed with 4% paraformaldehyde. Specimens were analyzed
using a LEICA DMR fluorescence microscope.
For live cell imaging, cells were cultured on Fluorodisk wells and
placed in a Solent scientific cell incubator with temperature and
CO2 control. Life cell analysis was performed for 12 hours from
72 h to 84 h after plating Time lapse series were obtained using a
BioRad Radiance 2100 MP confocal system (Zeiss/BioRad,
Hertfordshire, UK).
Confocal Raman microspectroscopy and imaging
FreshlyisolatedHSCsweregrownoncalciumfluoridecoverslips
and fixed at day 0, 4 and 7 with 2% paraformaldehyde in PBS for
15 minutes. In some experiments cells at day 0, 3 and 6 were
incubated with 25 mM deuturated arachidonic acid (20:4-d8) for
24 h,whereaftertheywerefixed.ForcalibrationoftheREandTAG
detectionpurelipidstandards(retinylpalmitateandtrioleylglycerol)
and mixtures of several ratios hereof were used. Non-resonant
Ramanspectroscopyandimagingexperimentswereperformedona
laser-scanning confocal Raman microspectrometer [13]. Imaging
experimentswereperformedbyraster-scanningthelaserbeamovera
LD or an intracellular region of interest and accumulating a full
Raman spectrum at each pixel (1 s/pixel at 23 mW 647.1-nm
excitationpower).Noiseintheresulting3D(spatial6spatial6spectral
dimension)datamatrixwasreducedbysingularvaluedecomposition
[13,16]. Raman images were constructed by plotting the integrated
intensity of the vibrational band of interest as a function of position.
Hierarchical cluster analysis (HCA) was performed on Raman
imaging data matrices to visualize regions in cells with high Raman
spectral similarities. In the cluster analysis routine, principal
component analysis scores were taken as input variables, squared
Euclidean distances were used as distance measure, and Ward’s
algorithmwasusedtopartitionRamanspectraintoclusters.Alldata
manipulations were performed in routines written in Matlab 6.5
(MathWorks, Natick, MA).
High-performance liquid chromatography and mass
spectrometry
Samples were kept under red light and all procedures were
carried out in brown vials to prevent retinoid isomerization and
oxidation. Lipids were extracted from equal protein amounts of
total cell homogenate of HSC at day 0, 4, 7 and 1 month after
isolation by the method of Bligh and Dyer [39]. Extracted lipids
were separated in a neutral and phospholipid fraction by
fractionation on a freshly prepared silica-G column (approximately
10 mg of 0,063–0,200 mm silica) [40]. Lipid extracts were
dissolved in methanol/chloroform (1/9, v/v) and loaded on top
of the silica column. Neutral lipids were eluted with two volumes
acetone, dried under nitrogen gas and stored at 220uC. Just
before HPLC-MS analysis, the neutral lipid fraction was
reconstituted in methanol/chloroform (1/1, v/v) and separated
on a Lichrospher RP18-e column (5 mm, 25064.6 mm; Merck,
Darmstadt, Germany). A gradient was generated from acetonitrile
to acetone/chloroform 85/15, v/v, at a constant flow rate of
1 ml/min. Mass spectrometry of lipids was performed using
Atmospheric Pressure Chemical Ionization (APCI) on a Biosys-
tems API-4000 Q-trap (MDS Sciex, Concord, Canada). The
system was controlled by Analyst version 1.4.2 software (MDS
Sciex, Concord, ON, Canada) and operated in positive ion mode
using the following settings: source temperature 420uC, nebulizer
gas (GS1) 5, nebulizer current 3 mA, curtain gas 10, collision gas
High and declustering potential 100 V. The optimal collision
energy was dependent on the type of experiment and was set to
+10 V (full scan mode) or +30 V (product ion mode). In all full
scan runs spectra were obtained from m/z 250–1100.
To identify the exact composition of high m/z value TAG
species, an enhanced product ion spectrum (optimal CE +35 V)
was made of all ions with an m/z value over 850. The solvents and
gradient used were similar as described above.
The phospholipid fraction was dissolved in methanol/acetoni-
trile/chloroform/water (46:20:17:17) and directly injected into the
mass spectrometer. Mass spectrometry of phospholipids was
performed using Electrospray Ionization (ESI) on a Biosystems
API-4000 Q-trap. The system was controlled by Analyst version
1.4.2 software and operated in positive mode (phosphatidylcholine
(PC), precursor scan of 184 m/z and phosphatidylethanolamine
(PE), neutral loss of 141 amu) and negative mode (phosphatidy-
linositol (PI), precursor scan of 241 m/z and phosphatidylserine
(PS), neutral loss of 87 amu), using the following settings: source
temperature 450uC, nebulizer gas (GS1) 45, curtain gas 10 and
collision gas High. Declustering potential and collision energy
were depending on the type of experiment and were respectively
for PC 120 V and 47 V, for PE 110 V and 30 V, for PI 2110 V
and 260 V and for PS 2100 V and 236 V.
Data analysis was performed using Analyst 1.4.2 software (MDS
Sciex, Concord, ON, Canada) and calibration curves of all lipid
classes were established under similar conditions as the samples.
Supporting Information
Figure S1 Migration of perinuclear LDs towards the
growing cell extensions in activated HSCs. To investigate
LD redistribution during HSC activation, freshly isolated HSCs
were incubated at day 0 with 25 mM Bodipy C-12 for 5 h. After
washing the excessive Bodipy C-12, cells were fixed (day 0) or
cultured for 4 days in the absence of dye before fixation (day 4).
Cells were analyzed by fluorescence microscopy.
(TIF)
Figure S2 Changes in protein levels of various enzymes
implicated in LD metabolism during HSC activation.
Western blots of equal amounts of total protein from isolated rat
HSC one day after plating (dy1) and 7 days after plating (dy7).
Blots were probed with antibodies against CTP:phosphocholine
cytidylyltransferase alpha (CCTa), diacylglycerol acyltransferase 2
(DGAT2), lecithin:retinol acyltransferase (LRAT), and b-actin
(ACT; loading control).
(TIF)
Figure S3 Incorporation of PUFAs in phosphatidylcho-
line species is not increased during HSC activation.
Phospholipid extracts of HSCs harvested at day 0, 4 and 7 were
analyzed by HPLC-MS as described. The results represent the
means 6 SEM of three experiments.
(TIF)
Movie S1 LD dynamics in activated HSC. Time lapse life
cell analysis was performed for 12 h on a typical HSC from 72 h
to 84 h after plating as described in method section. Frames were
taken every 30 minutes.
(AVI)
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